AI-powered pharmacovigilance: From reactive reporting to predictive risk
Pharmacovigilance (PV) is entering a new era that will transform safety conduct from today’s reactive reporting to predictive risk assessment. This transformation will be fueled by unprecedented volumes of real-world health data and operationalized by artificial intelligence (AI) and predictive analytics. In this paper, we discuss current, near-term and future AI applications, with examples of Parexel’s emerging AI solutions to advance efficiencies and insights in pharmacovigilance practice.
Related Insights
Article
Delivering AI-managed clinical research data: Parexel’s end-to-end automation strategy
Mar 11, 2025
Blog
AI Milestones: AI-enabled EKG reads and alerts save lives: human-AI collaboration in practice
Jun 6, 2024
Blog
Generative AI and how we can harness its power in clinical development
Sep 26, 2023
Article
Decentralized clinical trials - A more patient-centric approach
May 10, 2021
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Video
How to transition existing trials under EU-CTR
Feb 1, 2023
Video
FSP 2.0: Why Talent Development is the New Talent Acquisition
Oct 26, 2022
Playbook
The upward trend of FSP outsourcing
Sep 29, 2022
Blog
Including patients in DCT design
Sep 13, 2022
Related Insights
Article
Delivering AI-managed clinical research data: Parexel’s end-to-end automation strategy
Mar 11, 2025
Blog
AI Milestones: AI-enabled EKG reads and alerts save lives: human-AI collaboration in practice
Jun 6, 2024
Blog
Generative AI and how we can harness its power in clinical development
Sep 26, 2023
Article
Decentralized clinical trials - A more patient-centric approach
May 10, 2021
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Video
How to transition existing trials under EU-CTR
Feb 1, 2023
Video
FSP 2.0: Why Talent Development is the New Talent Acquisition
Oct 26, 2022
Playbook
The upward trend of FSP outsourcing
Sep 29, 2022
Blog
Including patients in DCT design
Sep 13, 2022